BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 22269342)

  • 1. Hypertension and future cardiovascular health in pediatric end-stage renal disease patients.
    Flynn JT
    Blood Purif; 2012; 33(1-3):138-43. PubMed ID: 22269342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The association between blood pressure and mortality in ESRD-not different from the general population?
    Lacson E; Lazarus JM
    Semin Dial; 2007; 20(6):510-7. PubMed ID: 17991196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiology of cardiovascular risk factors in chronic renal disease.
    Coresh J; Longenecker JC; Miller ER; Young HJ; Klag MJ
    J Am Soc Nephrol; 1998 Dec; 9(12 Suppl):S24-30. PubMed ID: 11443765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Addressing cardiovascular disease in patients with renal disease.
    Crook ED; Washington DO
    Ethn Dis; 2002; 12(4):S3-1-4. PubMed ID: 12477146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cardiovascular risk in hemodialysis in Spain: prevalence, management and target results (MAR study)].
    Portolés J; López-Gómez JM; Aljama P
    Nefrologia; 2005; 25(3):297-306. PubMed ID: 16053011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of hypertension in chronic kidney disease.
    Toto RD
    Semin Nephrol; 2005 Nov; 25(6):435-9. PubMed ID: 16298269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between chronic kidney disease prevalence and end-stage renal disease risk.
    Hallan SI; Vikse BE
    Curr Opin Nephrol Hypertens; 2008 May; 17(3):286-91. PubMed ID: 18408480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hypertension, dyslipidemia and cardiovascular risk in chronic renal disease].
    Ravera M; Paoletti E
    Ital Heart J Suppl; 2004 Jun; 5(6):436-44. PubMed ID: 15471148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Traditional and non-traditional risk factors as contributors to atherosclerotic cardiovascular disease in end-stage renal disease.
    Yao Q; Pecoits-Filho R; Lindholm B; Stenvinkel P
    Scand J Urol Nephrol; 2004; 38(5):405-16. PubMed ID: 15764253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The message for World Kidney Day 2009: hypertension and kidney disease--a marriage that should be prevented.
    Bakris GL; Ritz E;
    J Hypertens; 2009 Mar; 27(3):666-9. PubMed ID: 19262237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic kidney disease: a public health priority and harbinger of premature cardiovascular disease.
    Stenvinkel P
    J Intern Med; 2010 Nov; 268(5):456-67. PubMed ID: 20809922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diminished glomerular filtration rate as a marker of chronic kidney disease in hypertensive patients].
    Grabysa R; Cholewa M
    Pol Merkur Lekarski; 2008 Jun; 24(144):487-91. PubMed ID: 18702327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology and prevention of blood pressure-related renal disease.
    Whelton PK; Perneger TV; Brancati FL; Klag MJ
    J Hypertens Suppl; 1992 Dec; 10(7):S77-84. PubMed ID: 1291660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The challenge of cardiovascular risk factors in end-stage renal disease.
    Covic A; Gusbeth-Tatomir P; Goldsmith DJ
    J Nephrol; 2003; 16(4):476-86. PubMed ID: 14696749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac risk factors and the use of cardioprotective medications in patients with chronic renal insufficiency.
    Tonelli M; Bohm C; Pandeya S; Gill J; Levin A; Kiberd BA
    Am J Kidney Dis; 2001 Mar; 37(3):484-9. PubMed ID: 11228171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiology of renal and cardiovascular risk factors in Toba Aborigines.
    Bianchi ME; Farías EF; Bolaño J; Massari PU
    Ren Fail; 2006; 28(8):665-70. PubMed ID: 17162424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone mineral density in end-stage renal disease patients: association with wasting, cardiovascular disease and mortality.
    Matsubara K; Suliman ME; Qureshi AR; Axelsson J; Martola L; Heimbürger O; Barany P; Stenvinkel P; Lindholm B
    Blood Purif; 2008; 26(3):284-90. PubMed ID: 18421213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence evolution and impact of cardiovascular risk factors on allograft and renal transplant patient survival.
    Díaz JM; Gich I; Bonfill X; Solà R; Guirado L; Facundo C; Sainz Z; Puig T; Silva I; Ballarín J
    Transplant Proc; 2009; 41(6):2151-5. PubMed ID: 19715859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How often are patients with diabetes or hypertension being treated with partial nephrectomy for renal cell carcinoma? A population-based analysis.
    Abouassaly R; Finelli A; Tomlinson GA; Urbach DR; Alibhai SM
    BJU Int; 2011 Dec; 108(11):1806-12. PubMed ID: 21599823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ambulatory blood pressure monitoring in pediatric end-stage renal disease: chronic dialysis and transplantation.
    Sorof JM
    Blood Press Monit; 1999; 4(3-4):171-4. PubMed ID: 10490870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.